Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allena, Astrazeneca, BMS, Biontech, Daiichi, Inovio, Effrx, Enlivex, Epizyme, Innovent, Inovio, Kangtai, Lipocine, Macrogenics, Menarini, Merck, Merus, Minerva, Neurona, Novavax, Ocugen, OS, Pfizer, Rafael, Ridgeback, Transthera, Union, Y-mabs.